Drug
Gsk2190915 Milled
Gsk2190915 Milled: highest development phase Phase 1, developed by GlaxoSmithKline. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- GlaxoSmithKline
Trials
| Drug | Phase | Indication |
|---|---|---|
| GSK2190915 100mg milled tablet NCT01318980 | Phase 1 | Asthma |
Latest
No recent events.
Follow Gsk2190915 Milled on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.